{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:23:19Z","timestamp":1785842599329,"version":"3.56.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/aog.0b013e3181f386bb","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T19:52:36Z","timestamp":1285185156000},"page":"876-883","source":"Crossref","is-referenced-by-count":62,"title":["Endometrial Safety of Ultra-Low-Dose Estradiol Vaginal Tablets"],"prefix":"10.1097","volume":"116","author":[{"given":"James","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Nachtigall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian G.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Eugster-Hausmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210126","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/gme.0b013e3181a95581","article-title":"Efficacy and tolerability of local estrogen therapy for urogenital atrophy.","volume":"17","author":"Archer","year":"2010","journal-title":"Menopause"},{"key":"R2-13-20210126","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis.","volume":"61","author":"Bachmann","year":"2000","journal-title":"Am Fam Physician"},{"key":"R3-13-20210126","article-title":"Guidance for industry: estrogen and estrogen\/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms\u2014recommendations for clinical evaluation.","year":"2003"},{"key":"R5-13-20210126","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/00325481.1992.11701327","article-title":"Atrophic vaginitis. Can it be prevented as well as treated?","volume":"91","author":"Beard","year":"1992","journal-title":"Postgrad Med"},{"key":"R6-13-20210126","first-page":"228","article-title":"Postmenopausal vaginal atrophy and atrophic vaginitis.","volume":"314","author":"Pandit","year":"1997","journal-title":"Am J Med Sci"},{"issue":"3","key":"R7-13-20210126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/gme.0b013e318051718c","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R8-13-20210126","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.","volume":"112","author":"Simon","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R9-13-20210126","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/13697137.2010.481058","article-title":"Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy.","volume":"13","author":"Ulrich","year":"2010","journal-title":"Climacteric"},{"key":"R10-13-20210126","article-title":"Guideline on clinical investigation of medical products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women.","year":"2005"},{"key":"R11-13-20210126","article-title":"Cancer facts and figures 2009.","year":"2009"},{"key":"R13-13-20210126","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/gme.0b013e3181d0f6b9","article-title":"Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.","volume":"17","author":"Utian","year":"2010","journal-title":"Menopause"},{"key":"R14-13-20210126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R15-13-20210126","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4158\/EP.12.3.315","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.","volume":"12","author":"Cobin","year":"2006","journal-title":"Endocrinol Pract"},{"key":"R16-13-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.maturitas.2008.10.009","article-title":"The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy.","volume":"61","author":"Gompel","year":"2008","journal-title":"Maturitas"},{"key":"R17-13-20210126","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13697130701361657","article-title":"IMS updated recommendations on postmenopausal hormone therapy.","volume":"10","author":"Pines","year":"2007","journal-title":"Climacteric"},{"key":"R18-13-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R19-13-20210126","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF00051699","article-title":"Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States).","volume":"7","author":"Green","year":"1996","journal-title":"Cancer Causes Control"},{"key":"R20-13-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rigp.2005.01.001","article-title":"Endometrial cancer and HRT.","volume":"5","author":"Sturdee","year":"2005","journal-title":"Rev Gynaecol Pract"},{"key":"R21-13-20210126","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ajog.2009.02.032","article-title":"Incidence of endometrial hyperplasia.","volume":"200","author":"Reed","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0b013e3181f386bb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T12:38:25Z","timestamp":1636547905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201010000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181f386bb","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}